Teewinot Capital Advisers’s Eli Lilly LLY Stock Holding History

Teewinot Capital Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105M	Sell	114,611 -27,500	-19%	-$27.9M	8.41%	2
2025 Q4	$153M	Sell	142,111 -13,398	-9%	-$12.8M	11.21%	1
2025 Q3	$119M	Buy	155,509 +65,108	+72%	+$48.5M	9.22%	2
2025 Q2	$70.5M	Buy	90,401 +17,581	+24%	+$13.7M	5.79%	9
2025 Q1	$60.1M	Sell	72,820 -25,237	-26%	-$21M	6.15%	6
2024 Q4	$75.7M	Buy	98,057 +12,138	+14%	+$10.1M	7.72%	3
2024 Q3	$76.1M	Sell	85,919 -1,139	-1%	-$1.02M	7.69%	5
2024 Q2	$78.8M	Sell	87,058 -1,048	-1%	-$838K	7.77%	5
2024 Q1	$68.5M	Buy	88,106 +31,269	+55%	+$22.3M	7.18%	4
2023 Q4	$33.1M	Sell	56,837 -59,472	-51%	-$34.7M	5.01%	8
2023 Q3	$62.5M	Buy	116,309 +30,749	+36%	+$15.8M	9.98%	1
2023 Q2	$40.1M	Buy	85,560 +17,416	+26%	+$7.3M	6.79%	6
2023 Q1	$23.4M	Buy	68,144 +19,492	+40%	+$6.57M	4.63%	6
2022 Q4	$17.8M	Sell	48,652 -20,370	-30%	-$7.22M	3.98%	12
2022 Q3	$22.3M	Buy	+69,022	New	+$21.9M	5.11%	10

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Teewinot Capital Advisers's LLY Position: Q1 2026 in Review

Teewinot Capital Advisers reduced its Eli Lilly (LLY) stake by 19% in Q1 2026, selling an estimated $27.9M and leaving 114,611 shares worth $105M. The position accounts for 8.41% of the portfolio, ranked #2.

Teewinot Capital Advisers first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $153M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Teewinot Capital Advisers held 114,611 shares of Eli Lilly worth $105M as of Q1 2026.
Teewinot Capital Advisers sold 27,500 Eli Lilly shares in Q1 2026, an estimated $27.9M.
Eli Lilly made up 8.41% of Teewinot Capital Advisers's portfolio in Q1 2026, its #2 holding.
Teewinot Capital Advisers first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
Teewinot Capital Advisers's Eli Lilly position peaked at $153M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Teewinot Capital Advisers's 13F filing for Q1 2026, filed 15 May 2026.